Some studies have demonstrated that ketamine can inhibit GPX4 expression through the target lncRNA PVT1/miR-214-3p axis, thus inhibiting HCC cells (He et al., 2021). The gene discussed is GPX4; the disease is hepatocellular carcinoma.